Frontlight ResearchEarly access
CompletedNo phase
Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System
Key facts
- Who runs it
- Shockwave Medical, Inc.
- Where
- Chicago, Detroit, Los Angeles, New York, Seattle, and St Louis, United StatesSee the 6 sitesAlso in 2 other countries, 4 sites
- Trial code
- Status
- Completed
- People taking part
- 27 people enrolled
- Started
- 5 Feb 2015
- Ended
- 9 Dec 2024
- Type of study
- Interventional
- Treatments tested
- Mitral valve replacement
- Record updated
- 24 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Severe symptomatic mitral regurgitation (Stage D)
- High surgical risk for open mitral valve surgery
- Subject meets the anatomical eligibility criteria for available size(s)
- NYHA Class III or IV heart failure
Who cannot take part
- DMR deemed by the heart team to be operable
- Prohibitive risk, deemed too frail or listed for cardiac transplant
- Unsuitable cardiac structure
Where in United States
Also in 2 other countries, 4 sites
- Northwestern UniversityChicago, United States
- Henry Ford Health SystemDetroit, United States
- Cedars-Sinai Medical CenterLos Angeles, United States
- Columbia University Medical CenterNew York, United States
- University of Washington Medical CenterSeattle, United States
- Washington UniversitySt Louis, United States
About the trial
What the trial wants to find out
The purpose of this study is to evaluate the safety and initial performance of the Neovasc Tiara Mitral Transcatheter Heart Valve with the Tiara Transapical Delivery System.
The group in the trial
- TreatmentTreatment being tested
Transcatheter mitral valve replacement with the TIARA valve and transapical delivery system
Treatment: Mitral valve replacement
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Early Feasibility Study of the Neovasc Tiara™ Mitral Transcatheter Heart Valve With the Tiara™ Transapical Delivery System
- Record updated
- 24 July 2026